专利摘要:
1. Process for the industrial preparation of (Z)-1-phenyl-1-diethylaminocarbonyl-2- aminomethylcyclopropane of formula I : see diagramm : EP0200638,P7,F2 characterized by the use of the following successive reaction steps : i) 1-phenyl-2-oxo-3-oxa(3: 1: 0) bicyclohexane of formula II : see diagramm : EP0200638,P8,F1 is opened by treatment with a phthalimide salt in an organic solvent ; ii) (Z)-1-phenyl-2-phthalimidomethylcyclopropane-carboxylic acid of formula III thus obtained see diagramm : EP0200638,P8,F2 is treated with an acid chloride, and then the acid chloride thus formed is amidified by condensation with diethylamine in an organic solvent ; and iii) (Z)-1-phenyl-1-diethylaminocarbonyl-2- phthalimidomethylcyclopropane of formula IV thus obtained : see diagramm : EP0200638,P8,F3 is then treated with an alkylamine or a primary hydroxyalkylamine by itself or in the presence of a solvent to obtain, after hydrochlorination, the compound of abovementioned formula I.
公开号:SU1443797A3
申请号:SU864027356
申请日:1986-04-24
公开日:1988-12-07
发明作者:Бонно Бернар;Кусс Анри;Музен Жильбер;Патуазо Жан-Франсуа
申请人:П.Ф.Медикаман (Фирма);
IPC主号:
专利说明:


cm
one . 1443797 refers to improvement in pen f
The method for the preparation of 2-- (aminomethyl) -Y hydrochloride, M-diethyl-1-phenylic lopropane (Z) (a medicinal preparation of midalcyrane) which can be used in the chemical-chemical industry.
The purpose of the invention is to increase the yield of the target product.
Example 1.1 Phenylbtalimido 2-me; tpcc 1-cyclopropanecarboxylic acid (Z).
A suspension of 52.56 g (0.3 mol) of 1- (b of nyl-2-oxo-3-oxabicyclo (3: 1: 3) hexane and 61 g (0.33 mol) of potassium ltalimide in 270 ml of dimethyl termamide is kept under stirring at 150 for 12 hours
The pacTBOD obtained after cooling to room temperature is poured into 1000 ml of water. After extraction with ethyl acetate, the aqueous phase is acidified with acetic acid, then cooled with ice. The acid that crystallizes is filtered off, washed with water and recrystallized from ethnol to give 62.6 g of a highly purified compound (yield 65%).
Chromatography in thin cnoet (two parts of silicon - CF 254 Merck) Rf 0 (chloroform 85 - methanol 15).
IR: (KBG) 5 C 0: 1775, 1710 and 1650
PNR spectrum (CDCl1): cf, ppm (TMS 1.1 - 2 (n1, 3N, cyclopropane); 3VJ (d, 2H), CHiN); 7.15 (S, 5H,







aromatic); 7.75 (S, 4H, aromatic),
The described process can be carried out in the solvents x indicated in the table. one,
Example 2, H, H-Diethyl-1-phenyl, 2-phthalimidomethylcyclopropane,
Extraction suspension with ethyl acetate. Organized with water, dried with filtered and removed under reduced pressure. hydrochloric acid solution followed by ether crystals of the target with
In 30 ml of thionyl chloride (pe-.c course 71%), T, mp, 180.
Chromatography over silica - GF 24
16.2 g (0.05 mol) of 1-phenylphthalimido 2 methylcyclopropane carboxylic acid are added at ambient temperature. Get the solution after 2 h at room temperature. Oxalyl chloride can be used at this stage, the process is carried out at a boiling point temperature.
The solution is then boiled for 2 hours. After removing the excess thionyl chloride, the crude acid chloride in solution in 50 ml of methyl chloride is added dropwise to a solution of 1053 ml (0.1 mol) of diethylamine in 150 ml of chlorine.
0
five
0 panamida
methylene with stirring and chilling with an ice bath. Stir overnight with stirring at room temperature, wash the resulting solution with water, dry with anhydrous sodium sulfate, filter, and concentrate under reduced pressure. By adding isopropyl ether, 15.4 g of the title compound are obtained (vyháp 82%), m.p. 131 °,
Chromatography in a thin layer (silica CF 254 Meok); Rf 0.66 (chloroform 95 - methanol 5).
IR: (KBG) C 0: 1630, 1705 and 1770 cm.
PMR spectrum (CDCl-j): s, ppm (TMS):
0
five
0.65 (t, 3N. CH3); 1.15 (t, 3N, SN3): 1.25 (t, 1P, cyclopropane); 1.5-2.3 (t, 2H, cyclopropane); 3-3.7 (t, 5H, CHiN, cyclo-CH-N): 4.15 (dd,, cyclo-CH-N); 7.1 (S, 5H, aromatic); 7.6 (m, 4H, aromatic). Comparative results are obtained by replacing methylene chloride with chloroform.
Example 3. 2- (Aminome, thyl) -N, N-diethyl-1-phenylcyclopropanamide hydrochloride
a) A suspension of 18.82 g (0.05 mol) of the compound of Example 2 in 95 ml of an aqueous 40% methylamine solution is kept under stirring at room temperature for 5 hours.
The suspension is extracted 3 times. ethyl acetate. The organic phase is washed with water, dried over sodium sulfate. Filter and remove the solvent under reduced pressure. After adding a solution of hydrochloric acid in ethanol, then ether, 10 g of crystals of the target compound are obtained (yield 71%), T, mp, 180.
(two
Thin layer chromatography: silica - GF 245 Merck)
Rf 0.43 (chloroform 84 - methanol 14),
IR: (KVg) From 0: 1610 cm,
HMR spectrum (WLO): d, ppm (TMS): 0.8 (t, 3N, CH 3); 1.15 (t, 3N, CH O; 1.5-2.1 (w, 3N, cyclopropane); 3-3.7 (t, CH, N); 7.3 (S, aromatic),
b) A suspension of 60 g (0.159 mol) of the compound of Example 2 in 60 ml of ethanolamine is incubated for 1 hour at 90 ° C with stirring.
314
After consolidation, 300 ml of ice water is extracted 3 times with ethyl acetate.
The organic phase is washed with water, dried with sodium sulfate, filtered and the solvent is removed under reduced pressure.
After 3 N hydrochloric acid in ethanol is added, then 39.7 g of crystals of the target compound are obtained in ether (yield 88%). M.p. 178-180 ° C. Under similar CONDITIONS, various oxyalkylamines are used (Table 2).
权利要求:
Claims (1)
[1]
Invention Formula
Method for preparing 2-- (aminomethyl) -H, N- diethyl-1-phenyl-cyclopropanamide hydrochloride (Z) based on 1-phenyl-2-oxo-3-oxabicyclo (3,1,3) hexane and thionyl chloride of the formula
 N.
CH2CH3 CH2Cr1
based on 1-phenyl-2-oxo-3-oxabicyclo (3,1,3) hexane of the formula
j,
OL
0
and thionyl chloride, characterized in that, in order to increase the yield of the target product, 1-phenyl-2-oxo-3-oxabicyclo (3,1,3) hexane is reacted with potassium phthalimide in dimethylformamide or in dimethyl sulfoxide, or in 2-methylpyrrolidone, or in dimethylacetamide at 135–200 ° C, divided into 2- (phthalimido5 methyl) -1-phenylcyclopropanoic acid of the formula
he is about
treated with thionyl or oxalyl chloride at boiling, the resulting 2- (phthalimidomethyl) -1-phenylcyclopropanecarboxylic acid chloride is reacted with diethylamine in methylene chloride or chloroform, the resulting K, diethyl-2- (phthalimide methyl) 1-phenylcyclopropane is exposed to a lower alkyl- or oxyalkylamine and the resulting 2- (aninomethyl) -N, N-diethyl-1-phenylcyclopano-. the panamide is converted into hydrochloric acid by the action of hydrochloric acid.
Table 1
DM (A
Methylpyrrolidone
150 150 150 150 165 200
5/100
DMSO
135
ten
46
180
Editor N. L. Azarenko
Compiled by V. Volkov Tehred L. Oliynyk
Order 6402/58
Circulation 370
VNIIPI USSR State Committee
for inventions and discoveries 113035, Moscow, Zh-35, Raushsk nab, 4/5
table 2
Proofreader G. Reshetnik
Subscription
类似技术:
公开号 | 公开日 | 专利标题
SU1443797A3|1988-12-07|Method of producing chlorohydrate of 2-|-n,n-diethyl-1-phenylcyclopropaneamide |
DK173703B1|2001-07-09|Methods for preparing D, L- | and D- | -1-aryl-2-acylamido-3-fluoro-1-propanols, respectively
SU628812A3|1978-10-15|Organic compound producing method
JP2818958B2|1998-10-30|4- | -2-butylamine derivative and method for producing the same
US4562263A|1985-12-31|Process for producing 3-| serine
PL203275B1|2009-09-30|Method for the preparation of 5-cyanophthalide
JP6832946B2|2021-02-24|How to prepare kinase inhibitors and their intermediates
EP1484301A1|2004-12-08|PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
US5034541A|1991-07-23|Method of preparing 1-phenyl-1-diethylaminocarbonyl-2-phthalimidomethyl-cyclopropane-z
AU744538B2|2002-02-28|Method for the synthesis of quinoline derivatives
SU479290A3|1975-07-30|The method of obtaining 2- | -6,7 benzomorfan
HU196052B|1988-09-28|Process for optical resolving raceme mixtures of alpha-naphtyl-propionic acids
US4673761A|1987-06-16|Process for preparing anti-inflammatory cycloalkylidenemethylphenylacetic acid derivatives
JP4257573B2|2009-04-22|Method for producing R | α-lipoic acid
SU728712A3|1980-04-15|Method of preparing cinnamoyl amide
JP4450987B2|2010-04-14|Process for producing alkoxyfuranoneamine derivatives, compounds obtained by this process and uses of these compounds
EA011409B1|2009-02-27|Process for the preparation of chirally pure “h” nateglinide
RU2053226C1|1996-01-27|5-aminonaphthalene-1-substituted | sulfanilamides and method for production of 5-aminonaphthalene-1-substituted | sulfonyl amides
KR100235376B1|1999-12-15|2-aminonaphthyridine derivative and its preparation
TW201700458A|2017-01-01|Method for producing dicarboxylic acid compound
KR100235374B1|1999-12-15|Method for preparing optical isomers of a 2-amino naphthyridine derivative
JP6797839B2|2020-12-09|New manufacturing method of teriflunomide
TW202019872A|2020-06-01|Preparation method for fused tricyclic [gamma]-amino acid derivative and intermediate thereof
JPH0625208A|1994-02-01|Reagent for resolving racemic modification, its production and its use
SU603337A3|1978-04-15|Method of preparing derivatives of 1-|-4-|-piperazine
同族专利:
公开号 | 公开日
FR2581059B1|1988-04-22|
FR2581059A1|1986-10-31|
JPH0567136B2|1993-09-24|
ZA862929B|1986-12-30|
AR240695A1|1990-09-28|
EP0200638A1|1986-11-05|
YU44915B|1991-04-30|
PT82461B|1988-10-14|
DK191286A|1986-10-26|
MX162896B|1991-07-08|
YU65586A|1987-12-31|
FI87196C|1992-12-10|
FI861755A|1986-10-26|
CA1266486A|1990-03-06|
NO165143C|1991-01-09|
OA08241A|1987-10-30|
ES554321A0|1987-04-01|
IE861057L|1986-10-25|
PT82461A|1986-05-01|
IE59015B1|1993-12-15|
FI87196B|1992-08-31|
KR860008126A|1986-11-12|
AU5634386A|1986-10-30|
HU195182B|1988-04-28|
AT42273T|1989-05-15|
ES8704449A1|1987-04-01|
NO861573L|1986-10-27|
DK191286D0|1986-04-24|
NO165143B|1990-09-24|
KR940006764B1|1994-07-27|
DE3662877D1|1989-05-24|
JPS61251650A|1986-11-08|
DK170888B1|1996-03-04|
EP0200638B1|1989-04-19|
GR860980B|1986-08-25|
HUT40618A|1987-01-28|
FI861755A0|1986-04-25|
AU587613B2|1989-08-24|
引用文献:
公开号 | 申请日 | 公开日 | 申请人 | 专利标题
WO2012145234A3|2011-04-21|2012-12-13|Emory University|Cyclopropyl derivatives and methods of use|
RU2655919C2|2012-12-04|2018-05-30|Пьер Фабр Медикамент|Aminocyclobutane derivatives, method for preparing same and use thereof as drugs|FR2508035B1|1981-06-23|1984-06-29|Fabre Sa Pierre|FR2640972B1|1988-12-28|1991-04-19|Pf Medicament|
EP0747348A4|1994-02-22|1999-07-07|Asahi Chemical Ind|Aminoalkylcyclopropane derivative|
FR2752732B1|1996-08-28|1998-11-20|Pf Medicament|EXTENDED RELEASE GALENIC FORM OF MILNACIPRAN|
JP4418717B2|2004-06-24|2010-02-24|住友化学株式会社|Process for producing-1-phenyl-1-diethylaminocarbonyl-2-aminomethylcyclopropane hydrochloride|
JP4828863B2|2005-01-28|2011-11-30|住友化学株式会社|Process for producing-1-phenyl-1--2-phthalimidomethylcyclopropane|
WO2006132307A1|2005-06-10|2006-12-14|Pierre Fabre Medicament S.A.|Stabilized milnacipran formulation|
KR100772244B1|2005-07-20|2007-11-01|안국약품 주식회사|Method for the preparation of milnacipran hydrogen chloride salt|
SG160362A1|2006-04-17|2010-04-29|Sumitomo Chemical Co|Cyclic carboxylic acid|
JP5338035B2|2006-04-17|2013-11-13|住友化学株式会社|Process for producing polycyclic lactams|
WO2008104957A2|2007-02-28|2008-09-04|Ranbaxy Laboratories Limited|Novel polymorphic forms of milnacipran hydrochloride|
FR2941454B1|2009-01-29|2011-04-01|Pf Medicament|PROCESS FOR THE SYNTHESIS OF-MILNACIPRAN|
US20100274050A1|2009-04-23|2010-10-28|Glenmark Generics Limited|Solid milnacipran and process for the preparation of the same|
CN103242289B|2012-02-03|2015-01-07|暨明医药科技(苏州)有限公司|Preparation method of N,N-diallyl--2-aminomethyl-1-cyclopropanecarboxamide hydrochloride|
WO2014009767A1|2012-07-07|2014-01-16|Micro Labs Limited|An improved process for the preparation of 1-aryl 2-aminomethyl cyclopropane carboxyamidederivatives, their isomers and salts|
JP2015534464A|2012-10-09|2015-12-03|カリフォルニア インスティチュート オブ テクノロジー|In vivo and in vitro olefin cyclopropanation catalyzed by heme enzymes|
CN103613513B|2013-12-09|2016-01-20|上海现代制药股份有限公司|Milnacipran hydrochloride intermediate and its preparation method and application|
US9399762B2|2014-02-18|2016-07-26|California Institute Of Technology|Methods and systems for sulfimidation or sulfoximidation of organic molecules|
CN104058992A|2014-06-13|2014-09-24|上海现代制药股份有限公司|Crystal form of levomilnacipran hydrochloride|
EP3230258B1|2014-11-04|2019-06-26|Química Sintética, S.A.|Process for the preparation of -milnacipran|
法律状态:
优先权:
申请号 | 申请日 | 专利标题
FR8506335A|FR2581059B1|1985-04-25|1985-04-25|PROCESS FOR THE PREPARATION OF PHENYL-1 HYDROCHLORIDE DIETHYL AMINO CARBONYL-1 AMINOMETHYL-2 CYCLOPROPANE |LV920505A| LV5076A3|1985-04-25|1992-12-28|Method of Acquisition of 2--N, N-diethyl-1-phenylcyclopropanamideChlorohydrate|
[返回顶部]